Franz B Humer - Net Worth and Insider Trading

Franz B Humer Net Worth

The estimated net worth of Franz B Humer is at least $666,210 dollars as of 2024-08-24. Franz B Humer is the Director of Allogene Therapeutics Inc and owns about 255,253 shares of Allogene Therapeutics Inc (ALLO) stock worth over $666,210. Details can be seen in Franz B Humer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Franz B Humer has not made any transactions after 2024-05-30 and currently still holds the listed stock(s).

Transaction Summary of Franz B Humer

To

Franz B Humer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Franz B Humer owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , Citigroup Inc (C) , and Kite Pharma Inc (KITE) .

Click here to see the complete history of Franz B Humer’s form 4 insider trades.

Insider Ownership Summary of Franz B Humer

Ticker Comapny Transaction Date Type of Owner
ALLO Allogene Therapeutics Inc 2024-05-30 director
C Citigroup Inc 2012-04-17 director
KITE Kite Pharma Inc 2017-10-03 director

Franz B Humer Latest Holdings Summary

Franz B Humer currently owns a total of 1 stock. Franz B Humer owns 255,253 shares of Allogene Therapeutics Inc (ALLO) as of May 30, 2024, with a value of $666,210.

Latest Holdings of Franz B Humer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALLO Allogene Therapeutics Inc 2024-05-30 255,253 2.61 666,210

Holding Weightings of Franz B Humer


Franz B Humer Form 4 Trading Tracker

According to the SEC Form 4 filings, Franz B Humer has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 11,200 shares on May 30, 2024, which brought Franz B Humer around $26,208.

Insider Trading History of Franz B Humer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Franz B Humer Trading Performance

GuruFocus tracks the stock performance after each of Franz B Humer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franz B Humer is 3.67%. GuruFocus also compares Franz B Humer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franz B Humer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Franz B Humer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Franz B Humer

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Franz B Humer Ownership Network

Ownership Network List of Franz B Humer

No Data

Ownership Network Relation of Franz B Humer

Insider Network Chart

Franz B Humer Owned Company Details

What does Allogene Therapeutics Inc do?

Who are the key executives at Allogene Therapeutics Inc?

Franz B Humer is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .

Allogene Therapeutics Inc (ALLO) Insider Trades Summary

Over the past 18 months, Franz B Humer made 1 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 11,200. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 10,000 shares made by Stephen Mayo .

In summary, during the past 3 months, insiders sold 29,841 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 29,841 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.

Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allogene Therapeutics Inc Insider Transactions

No Available Data

Franz B Humer Mailing Address

Above is the net worth, insider trading, and ownership report for Franz B Humer. You might contact Franz B Humer via mailing address: 388 Greenwich Street, 17th Floor, New York Ny 10013.

Discussions on Franz B Humer

No discussions yet.